Glaxo Sticks By LYMErix
May 21, 2001
GlaxoSmithKline, the manufacturer of LYMErix, insists that the vaccine does not cause arthritis. However, many consumers who took the vaccine tend to disagree. GlaxoSmithKline developed LYMErix to prevent the tick-borne illness Lyme disease. The Food & Drug Administration approved LYMErix in 1999. Since its introduction, 1.4 million vaccines have been administered.
While the FDA maintains that LYMErix is safe, the agency convened an advisory panel to discuss the vaccine. At that panel meeting, many people who took LYMErix told of how they developed arthritis or arthritis type pain after receiving the vaccine.
Lyme disease is usually caused by tick bites. The condition can create flu-like symptoms and a rash. If left untreated, Lyme disease can cause chronic arthritis, and may affect the brain, heart, and other organs.
To date, the FDA has received 132 reports indicating a connection between LYMErix and arthritis. GlaxoSmithKline maintains that LYMErix is safe, and the company plans to have independent specialists review the reports.
-- Article Courtesy of InjuryBoard.com
More ...
- Physicians Reporting More Side Effects of Smallpox Vaccine
- British Health Agency Says MMR Vaccine is Safe
- Boy Paralyzed by Polio Vaccine Dies
.